Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Long-term toxicity of cisplatin in germ-cell tumor survivors.
Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic study.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Long-term toxicity of cisplatin in germ-cell tumor survivors.
Long-term toxicity of cisplatin in germ-cell tumor survivors. Ann Oncol. 2017 Nov 01; 28(11):2670-2679.
View in:
PubMed
subject areas
Antineoplastic Agents
Cisplatin
Humans
Neoplasms, Germ Cell and Embryonal
Neoplasms, Second Primary
Prognosis
Risk Factors
Survivors